Gabriel S. Morris - 16 Sep 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Signature
/s/ Gabriel Morris
Issuer symbol
IMMX
Transactions as of
16 Sep 2025
Net transactions value
+$5,122
Form type
4
Filing time
17 Sep 2025, 17:20:32 UTC
Previous filing
23 Jun 2025
Next filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morris Gabriel S CFO, Director C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES /s/ Gabriel Morris 17 Sep 2025 0001889967

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Purchase $5,122 +2,600 +0.9% $1.97 290,659 16 Sep 2025 Direct
holding IMMX Common Stock 270,844 16 Sep 2025 See footnote F1
holding IMMX Common Stock 24,141 16 Sep 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F2 Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.